We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECPG icon
1151
Encore Capital Group
ECPG
$2.06B
$1.14M 0.01%
29,360
+4,275
+17% +$155K
VYX icon
1152
NCR Voyix
VYX
$1.19B
$1.14M 0.01%
49,409
+10,842
+28% +$180K
TRS icon
1153
TriMas Corp
TRS
$1.45B
$1.14M 0.01%
+35,887
New +$982K
SIBN icon
1154
SI-BONE Inc
SIBN
$792M
$1.13M 0.01%
+37,872
New +$922K
ELMSW
1155
CALL
DELISTED
Electric Last Mile Solutions, Inc. Warrant
ELMSW
$1.13M 0.01%
+83,329
New +$168K
CENT icon
1156
Central Garden & Pet Co
CENT
$2.8B
$1.13M 0.01%
36,453
+14,730
+68% +$471K
CYD icon
1157
China Yuchai International
CYD
$1.72B
$1.13M 0.01%
68,930
+33,176
+93% +$580K
NET icon
1158
Cloudflare
NET
$93.9B
$1.13M 0.01%
14,802
-79,280
-84% -$5.2M
CERE
1159
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.12M 0.01%
+67,772
New +$880K
SAR icon
1160
Saratoga Investment
SAR
$319M
$1.12M 0.01%
53,650
-9,901
-16% -$199K
SHC icon
1161
Sotera Health
SHC
$5.01B
$1.12M 0.01%
+40,747
New +$1.09M
JWS.WS
1162
CALL
DELISTED
Jaws Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary
JWS.WS
$1.12M 0.01%
+83,332
New +$179K
OPK icon
1163
Opko Health
OPK
$1.24B
$1.11M 0.01%
+280,836
New +$1.17M
BBD icon
1164
Banco Bradesco
BBD
$38.8B
$1.1M 0.01%
254,072
-155,165
-38% -$567K
HMCOU
1165
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
$1.1M 0.01%
+100,000
New +$1.11M
JCI icon
1166
Johnson Controls International
JCI
$84.7B
$1.1M 0.01%
+23,621
New +$1.05M
ABMD
1167
DELISTED
Abiomed Inc
ABMD
$1.1M 0.01%
3,389
+463
+16% +$128K
MSBI icon
1168
Midland States Bancorp
MSBI
$711M
$1.1M 0.01%
61,340
-22,111
-26% -$360K
OHI icon
1169
Omega Healthcare
OHI
$15.3B
$1.1M 0.01%
+30,162
New +$1.02M
NNN icon
1170
NNN REIT
NNN
$9.39B
$1.09M 0.01%
+26,760
New +$1.01M
OMAB icon
1171
Grupo Aeroportuario Centro Norte
OMAB
$5.28B
$1.09M 0.01%
21,198
+13,544
+177% +$605K
CAI
1172
DELISTED
CAI International, Inc.
CAI
$1.09M 0.01%
+35,021
New +$1.06M
KSU
1173
DELISTED
Kansas City Southern
KSU
$1.09M 0.01%
5,351
-55,326
-91% -$10.4M
FOLD
1174
DELISTED
Amicus Therapeutics
FOLD
$1.09M 0.01%
+47,199
New +$965K
CYTK icon
1175
Cytokinetics
CYTK
$10.9B
$1.09M 0.01%
52,278
-155,175
-75% -$2.84M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.